Jazz Pharmaceuticals (JAZZ) Prices IPO Between $24-26 Per Share

May 17, 2007 7:50 AM EDT
Jazz Pharmaceuticals, Inc (Nasdaq: JAZZ) has filed an amended S-1 statement with the SEC. The Company now expects the public offering price to be between $24.00-26.00 per share. The Company is offering 6.0 million shares. The company plans to list on the Nasdaq Global Market under the symbol "JAZZ".

The offering is being made through Credit Suisse, Morgan Stanley, Lehman Bros. and Natexis Bleichroeder.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

You May Also Be Interested In

Related Categories


Add Your Comment